Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CARRIER STATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02953600
What this trial is testing

Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration

Who this might be right for
HBV Carrier
Taipei Medical University WanFang Hospital 72
Not applicableWithdrawnNCT00084370
What this trial is testing

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer
University of Alabama at Birmingham
Not applicableWithdrawnNCT01663584
What this trial is testing

Multi-disease Carrier Screening Test Validation

Who this might be right for
Spinal Muscular Atrophy (SMA)Carrier ScreeningGenetic Testing
Natera, Inc.
Large-scale testing (Phase 3)UnknownNCT03407157
What this trial is testing

Oral Probiotic Supplementation in Pregnancy to Reduce Group B Streptococcus Colonization

Who this might be right for
Group B Streptococcus Carrier in Childbirth
University of British Columbia 168
Not applicableTemporarily pausedNCT03602040
What this trial is testing

A Psychoeducational Intervention Supporting Patients With an Inherited Cardiac Condition

Who this might be right for
Inherited Cardiac Conduction DisorderCardiomyopathies
King's College London 24
Not applicableNot Yet RecruitingNCT05469906
What this trial is testing

Evaluation at 5 and 10 Years of Renal Transplant Patients

Who this might be right for
Transplant; Complication, Failure
University Hospital, Brest 116
Post-approval studies (Phase 4)Study completedNCT05430750
What this trial is testing

Global Warming Impact of Nitrous Oxide

Who this might be right for
Global Warming Effect of Nitrous Oxide
Sir Ganga Ram Hospital 102
Testing effectiveness (Phase 2)WithdrawnNCT00941356
What this trial is testing

Evaluation of the Efficacy of Bio-K+ Cl-1285® In the Nasal Decolonization of Methicillin Resistant Staphylococcus Aureus (MRSA) Carrier Patients

Who this might be right for
MRSA Colonization
Bio-K Plus International Inc.
Not applicableStudy completedNCT04015323
What this trial is testing

The Efficacy of Interferential Current Treatment on Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Ege University 61
Large-scale testing (Phase 3)Study completedNCT01338714
What this trial is testing

The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function

Who this might be right for
Liver Dysfunction
Taipei City Hospital 58
Testing effectiveness (Phase 2)Study completedNCT02314156
What this trial is testing

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma In Situ+6 more
Northwestern University 67
Not applicableNot Yet RecruitingNCT07402122
What this trial is testing

Registry for Duchenne and Becker Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)Becker Muscular DystrophyDystrophinopathy Symptomatic Female Carrier
Dr. Andreas Ziegler 1,500
Testing effectiveness (Phase 2)Study completedNCT01998841
What this trial is testing

Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 252
Not applicableEnded earlyNCT04717453
What this trial is testing

Study to Characterize Rate of Ureagenesis in Patients With Ornithine Transcarbamylase (OTC) Deficiency

Who this might be right for
Ornithine Transcarbamylase Deficiency
Ultragenyx Pharmaceutical Inc 1
Early research (Phase 1)Study completedNCT00892736
What this trial is testing

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Who this might be right for
Basal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more
National Cancer Institute (NCI) 98
Large-scale testing (Phase 3)UnknownNCT04775030
What this trial is testing

Methodology for Developing an Occlusal Appliance With CBD Active Carrier

Who this might be right for
Temporomandibular DisorderMyofascial PainCannabis+3 more
Medical University of Silesia 40
Testing effectiveness (Phase 2)UnknownNCT01772979
What this trial is testing

Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer

Who this might be right for
BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype
Catholic University of the Sacred Heart 100
Not applicableStudy completedNCT07310641
What this trial is testing

Descriptive Analysis of Preimplantation Genetic Test (PGT)in Couples With Polycystic Kidney Disease (PKD). In the ADPKD Subgroup Evaluation of Outcomes and Complications Comparing Couples in Which the Father is Affected With Couples in Which the Mother is Affected

Who this might be right for
Polycystic Kidney DiseaseAssisted Reproductive TechnologyPreimplantation Genetic Testing (PGT)
Azienda Sanitaria Universitaria Integrata del Trentino 44
Testing effectiveness (Phase 2)UnknownNCT00080756
What this trial is testing

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
City of Hope Medical Center 11
Not applicableLooking for participantsNCT05474430
What this trial is testing

Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity

Who this might be right for
Carrier StateRespiratory Infections
Philip Polgreen 160
Next Page